Remove Business Development Remove Development Remove Gene Therapy Remove Reagent
article thumbnail

Expert view: What’s next for cell and gene therapy?

Drug Discovery World

What are the global innovations in cell and gene therapy? What opportunities and challenges are emerging and can therapies get to market faster? This issue has become a key focus for the ISCT, and we have been working to identify and develop initiatives to help alleviate these shortages.” The solution?

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Viral vector manufacturing At the Advanced Therapies Awards ceremony, Dr Luigi Naldini, Director of the San Raffaele Telethon Institute for Gene Therapy, was awarded a Lifetime Achievement Award in recognition of ‘extraordinary contributions to gene therapy’, a field he has helped shape through his pioneering work on lentiviral vectors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Dopavision, a DTx company in the eye health space, has brought on ophthalmology and neuroscience expert Dirk Sauer , a veteran of Novartis Pharma, to advise the company as it continues to develop MyopiaX, a digital therapeutic for childhood myopia control. AI and robotics hires. McKinnell, Jr. to support the company’s growth.

article thumbnail

GenScript expands capacity for cell and gene therapy programmes

Drug Discovery World

GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies. . The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials.